Researchers make breakthrough in the cause of premature birth

May 30, 2012

(Medical Xpress) -- A significant breakthrough on why women go into labour early or develop the disease  pre-eclampsia has been made by scientists. The discovery concerning the conditions which threaten the life of both the newborn baby and the mother was made by researchers at the Trinity Biomedical Sciences Institute (TBSI) at Trinity College Dublin and Coombe Women and Infants University Hospital.  The findings have just been published in the Journal of Immunology.  

Mothers who deliver their babies early or develop pre-eclampsia have been shown to have higher levels of the baby's DNA in their blood. The researchers have shown that this DNA is seen as foreign by the mother's immune system, being sensed by a protein called Toll-like receptor-9 (TLR9) which provokes an inflammatory reaction that leads to pregnancy loss and early delivery. The research has shown that this response can be blocked by drugs that target TLR9, including chloroquin  − a medicine used in pregnancy for other diseases.

“Premature birth is the biggest cause of infant mortality worldwide. Why babies are born early, as defined as less than 37 weeks gestation, is not known,” explained Professor of Pathology John O'Leary at TCD and the Coombe, senior physician on the research.

“The normal job of TLR9 is to sense DNA from viruses and bacteria. In preterm however, where the baby's DNA enters the mother's blood, TLR9 does mischief causing early birth. Our study makes TLR9 an attractive target to stop preterm birth,” continued Professor of Biochemistry, Luke O'Neill of the School of Biochemistry and Immunology in Trinity Biomedical Sciences Institute and senior scientist.

The work is published in the current issue of the Journal of Immunology, with Dr Andrea Scharfe Nugent, consultant obstetrician and gynaecologist at Mount Carmel Hospital, and microbiologist Dr Sinead Corr as joint lead authors. The research group, which also involves Clinical Professor of Obstetrics and  Gynaecology, Sean Daly, at TCD and consultant in maternal foetal medicine at the  Coombe, and obstetrical clinical lead, are exploring the prospect of developing the discovery for treating women at risk of preterm birth or pre-eclampsia. The research was funded by Science Foundation Ireland and the Friends of the Coombe Hospital.

“This work is an excellent example of Trinity scientists working with clinical colleagues on important medical problems,” concluded Professor O'Neill who is also academic director of the newly opened Trinity Institute.

Explore further: Antidepressants -- not depression -- increase risk of preterm birth, study shows

More information: TLR9 Provokes Inflammation in Response to Fetal DNA: Mechanism for Fetal Loss in Preterm Birth and Preeclampsia. Scharfe-Nugent A, Corr SC, Carpenter SB, Keogh L, Doyle B, Martin C, Fitzgerald KA, Daly S, O'Leary JJ, O'Neill LA. J Immunol. 2012 Jun 1;188(11):5706-12. www.ncbi.nlm.nih.gov/pubmed/22544937

Related Stories

Antidepressants -- not depression -- increase risk of preterm birth, study shows

May 28, 2012
(Medical Xpress) -- Women who are depressed during pregnancy are not at higher risk of giving birth prematurely than non-depressed women — but those who take antidepressants during pregnancy seem to be, a new study ...

Test for pre-eclampsia developed

May 4, 2011
(Medical Xpress) -- Scientists at King’s have pioneered a new method of identifying early in pregnancy which healthy first-time mothers are at risk of developing pre-eclampsia, a potentially life threatening condition ...

A major step forward in fighting superbugs

July 29, 2011
New research has identified a novel mechanism by which humans can defend themselves against the well known hospital superbug, Clostridium difficile.  The study provides us with critical information for the development ...

Caesarean link to respiratory infections in babies

November 1, 2011
(Medical Xpress) -- A new study from Perth’s Telethon Institute for Child Health Research has found that babies born by elective caesarean are more likely to be admitted to hospital with the serious respiratory infection, ...

Three in four women below recommended exercise levels during pregnancy, research shows

June 24, 2011
(Medical Xpress) -- The majority of women in Ireland do not reach the recommended levels of exercise during pregnancy, according to new research.

Novel respiratory monitor for premature babies ready for FDA review

April 4, 2012
Researchers at the Technion-Israel Institute of Technology have developed a novel device to continuously and systematically monitor the dynamics of premature babies' breathing. The small, noninvasive device dubbed "Pneumonitor," ...

Recommended for you

Gene immunotherapy protects against multiple sclerosis in mice

September 21, 2017
A potent and long-lasting gene immunotherapy approach prevents and reverses symptoms of multiple sclerosis in mice, according to a study published September 21st in the journal Molecular Therapy. Multiple sclerosis is an ...

New academic study reveals true extent of the link between hard water and eczema

September 21, 2017
Hard water damages our protective skin barrier and could contribute to the development of eczema, a new study has shown.

Exposure to pet and pest allergens during infancy linked to reduced asthma risk

September 19, 2017
Children exposed to high indoor levels of pet or pest allergens during infancy have a lower risk of developing asthma by 7 years of age, new research supported by the National Institutes of Health reveals. The findings, published ...

Cholesterol-like molecules switch off the engine in cancer-targeting 'Natural Killer' cells

September 18, 2017
Scientists have just discovered how the engine that powers cancer-killing cells functions. Crucially, their research also highlights how that engine is fuelled and that cholesterol-like molecules, called oxysterols, act as ...

MicroRNA helps cancer evade immune system

September 18, 2017
The immune system automatically destroys dysfunctional cells such as cancer cells, but cancerous tumors often survive nonetheless. A new study by Salk scientists shows one method by which fast-growing tumors evade anti-tumor ...

'Exciting' discovery on path to develop new type of vaccine to treat global viruses

September 15, 2017
Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.